David Domzalski
Chief Executive Officer at VYNE THERAPEUTICS INC.
Net worth: 2 M $ as of 31/03/2024
Profile
David Domzalski currently works at VYNE Therapeutics, Inc., as President, Chief Executive Officer & Director from 2020.
Mr. Domzalski also formerly worked at VYNE Pharmaceuticals Ltd., as Chief Executive Officer & Director from 2018 to 2020, Menlo Therapeutics, Inc., as President, Chief Executive Officer & Director, Warner Chilcott, Inc., as Vice President-Sales & Marketing from 2003 to 2008, Sanofi-Synthelabo, Inc., as Vice President, Jazz Pharmaceuticals Commercial Corp., as Senior Vice President & General Manager from 2008 to 2009, and Leo Pharma, Inc., as Vice President-Sales & Marketing from 2009 to 2013.
Mr. Domzalski received his undergraduate degree from Muhlenberg College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VYNE THERAPEUTICS INC
3.50% | 01/04/2024 | 494,160 ( 3.50% ) | 2 M $ | 31/03/2024 |
David Domzalski active positions
| Companies | Position | Start |
|---|---|---|
| VYNE THERAPEUTICS INC. | Chief Executive Officer | 01/03/2020 |
Former positions of David Domzalski
| Companies | Position | End |
|---|---|---|
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Chief Executive Officer | 09/03/2020 |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Sales & Marketing | 01/07/2013 |
Jazz Pharmaceuticals Commercial Corp.
 Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/01/2009 |
Warner Chilcott, Inc.
 Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Warner Chilcott, Inc. develops and manufactures drugs. It makes women's health care and urology prescription drugs, dermatology and cardiology drugs. The company is headquartered in Rockaway, NJ. | Sales & Marketing | 01/01/2008 |
| VYNE THERAPEUTICS INC. | Chief Executive Officer | - |
Training of David Domzalski
| Muhlenberg College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
Warner Chilcott, Inc.
Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Warner Chilcott, Inc. develops and manufactures drugs. It makes women's health care and urology prescription drugs, dermatology and cardiology drugs. The company is headquartered in Rockaway, NJ. | Health Technology |
| Sanofi-Synthelabo, Inc. | Health Technology |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |
| VYNE Therapeutics, Inc. |
- Stock Market
- Insiders
- David Domzalski
